SMAD3 and prostate adenocarcinoma: In conclusion, this study emphasizes the significance of EPHB1-GSK3B-SMAD3 signaling in PRAD progression and provides a new theoretical basis and experimental support for future studies on the molecular mechanism of PRAD and the development of clinical treatment strategies for cancer.